Literature DB >> 25427123

Pancreatic adenocarcinoma.

David P Ryan, Theodore S Hong, Nabeel Bardeesy.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25427123     DOI： 10.1056/NEJMc1412266

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  197 in total

1.  Glycogen synthase kinase-3β ablation limits pancreatitis-induced acinar-to-ductal metaplasia.

Authors:  Li Ding; Geou-Yarh Liou; Daniel M Schmitt; Peter Storz; Jin-San Zhang; Daniel D Billadeau
Journal:  J Pathol       Date:  2017-07-27       Impact factor: 7.996

2.  Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer.

Authors:  Tulasigeri M Totiger; Supriya Srinivasan; Venkatakrishna R Jala; Purushottam Lamichhane; Austin R Dosch; Alexander A Gaidarski; Chandrashekhar Joshi; Shobith Rangappa; Jason Castellanos; Praveen Kumar Vemula; Xi Chen; Deukwoo Kwon; Nilesh Kashikar; Michael VanSaun; Nipun B Merchant; Nagaraj S Nagathihalli
Journal:  Mol Cancer Ther       Date:  2018-11-07       Impact factor: 6.261

Review 3.  Pancreatic cancer from bench to bedside: molecular pathways and treatment options.

Authors:  Christoforos Kosmidis; Konstantinos Sapalidis; Efstathios Kotidis; Nikolaos Mixalopoulos; Paul Zarogoulidis; Drosos Tsavlis; Sofia Baka; Yan-Gao Man; John Kanellos
Journal:  Ann Transl Med       Date:  2016-05

4.  Downregulation of NUF2 inhibits tumor growth and induces apoptosis by regulating lncRNA AF339813.

Authors:  Peng Hu; Jianying Shangguan; Leida Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

5.  Predicting a response to FOLFIRINOX in pancreatic cancer.

Authors:  Ryan D Nipp; David P Ryan
Journal:  J Natl Cancer Inst       Date:  2015-05-29       Impact factor: 13.506

6.  Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer.

Authors:  Michela Capello; Leonidas E Bantis; Ghislaine Scelo; Yang Zhao; Peng Li; Dilsher S Dhillon; Nikul J Patel; Deepali L Kundnani; Hong Wang; James L Abbruzzese; Anirban Maitra; Margaret A Tempero; Randall Brand; Matthew A Firpo; Sean J Mulvihill; Matthew H Katz; Paul Brennan; Ziding Feng; Ayumu Taguchi; Samir M Hanash
Journal:  J Natl Cancer Inst       Date:  2017-04-01       Impact factor: 13.506

7.  mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer.

Authors:  David R Driscoll; Saadia A Karim; Makoto Sano; David M Gay; Wright Jacob; Jun Yu; Yusuke Mizukami; Aarthi Gopinathan; Duncan I Jodrell; T R Jeffry Evans; Nabeel Bardeesy; Michael N Hall; Brian J Quattrochi; David S Klimstra; Simon T Barry; Owen J Sansom; Brian C Lewis; Jennifer P Morton
Journal:  Cancer Res       Date:  2016-10-06       Impact factor: 12.701

8.  Methylation of immune-regulatory cytokine genes and pancreatic cancer outcomes.

Authors:  Brian Z Huang; Alexandra M Binder; Catherine A Sugar; Chun R Chao; Veronica Wendy Setiawan; Zuo-Feng Zhang
Journal:  Epigenomics       Date:  2020-09-01       Impact factor: 4.778

9.  Endoscopic ultrasound-guided choledochoduodenostomy with a lumen-apposing, self-expandable fully covered metal stent for palliative biliary drainage.

Authors:  Joshua Blake French; Adam Wesley Coe; Rishi Pawa
Journal:  Clin J Gastroenterol       Date:  2016-03-08

Review 10.  Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.

Authors:  Chiara Birtolo; Vay Liang W Go; Andrzej Ptasznik; Guido Eibl; Stephen J Pandol
Journal:  Pancreas       Date:  2016-01       Impact factor: 3.327
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.